Whole Earth Brands, Inc.

Whole Earth Brands, Inc. (Nasdaq: FREE), relating to its proposed sale to affiliates of Sababa Holdings FREE, LLC. Under the terms of the agreement, FREE shareholders are expected to receive $4.875 in cash per share they own.

HireRight Holdings Corp.

HireRight Holdings Corp. (NYSE: HRT), relating to its proposed sale to affiliates of General Atlantic, L.P. and Stone Point Capital LLC. Under the terms of the agreement, HRT shareholders are expected to receive $14.35 in cash per share they own.

Masonite International Corp.

Masonite International Corp. (NYSE: DOOR), relating to its proposed sale to Owens Corning. Under the terms of the agreement, DOOR shareholders are expected to receive $133.00 in cash per share they own.

ZeroFox Holdings, Inc.

ZeroFox Holdings, Inc. (Nasdaq: ZFOX), relating to its proposed sale to Haveli Investments. Under the terms of the agreement, ZFOX shareholders are expected to receive $1.14 in cash per share they own.

Kinnate Biopharma Inc.

Kinnate Biopharma Inc. (Nasdaq: KNTE), relating to its proposed sale to XOMA Corp. Under the terms of the agreement, KNTE shareholders are expected to receive $2.3352 in cash plus an additional cash amount not exceeding $0.2527 per share they own.

Discover Financial Services

Discover Financial Services (NYSE: DFS), relating to its proposed sale to Capital One Financial Corp. Under the terms of the agreement, DFS shareholders are expected to receive 1.0192 shares of Capital One per share they own.

Enerplus Corp.

Enerplus Corp. (NYSE: ERF), relating to its proposed merger with Chord Energy Corp. Under the terms of the agreement, ERF shareholders are expected to receive 0.10125 shares of Chord plus $1.84 in cash per share they own.

Diamondback Energy, Inc.

Diamondback Energy, Inc. (Nasdaq: FANG), relating to its proposed merger with Endeavor Energy Resources L.P. Under the terms of the agreement, FANG shareholders are expected to own approximately 60.5% of the combined company.

CymaBay Therapeutics, Inc.

CymaBay Therapeutics, Inc. (Nasdaq: CBAY), relating to its proposed sale to Gilead Sciences, Inc. Under the terms of the agreement, CBAY shareholders will receive $32.50 in cash per share they own.

Assure Holdings Corp.

Assure Holdings Corp. (Nasdaq: IONM), relating to its proposed merger with Danam Health, Inc. Under the terms of the agreement, Assure shareholders are expected to own approximately 10% of the combined company.